Loading…
Biogen is a biotechnology company focused on developing medicines for hard-to-treat diseases in neurology, immunology, and rare diseases. The company uses cutting-edge science to advance potential breakthrough therapies through its pipeline.
AI named Biogen from December 2025 to March 2026.